The American Reporter
Wednesday, February 8, 2023
  • World
  • National
  • Science
  • Business
  • Health
  • Education
  • Lifestyle
  • Entertainment
  • Sports
  • Technology
No Result
View All Result
  • World
  • National
  • Science
  • Business
  • Health
  • Education
  • Lifestyle
  • Entertainment
  • Sports
  • Technology
No Result
View All Result
The American Reporter
No Result
View All Result
Home Business

How Morocco’s King intends to make his country a regional champion of vaccine production

mm by James Boley
July 12, 2021
in Business
420
VIEWS
Share on FacebookShare on Twitter
Maroc: lancement et signature de conventions relatives à la fabrication et mise en seringue du vaccin anti-Covid19 et autres vaccins

Initiated by King Mohammed VI, an ambitious vaccine manufacturing project aims to make the Kingdom a regional champion in the vaccine industry. Morocco plans to produce 5 million doses of Covid19 vaccine per month in the short term, before moving to a higher rate in the medium term. The country is considered as one of the most active in fighting the pandemic in Africa, and has already managed to vaccinate 10 million moroccans out of 30.

According to many experts, Morocco has not only contained the Covid-19 pandemic, but has also turned it into an opportunity to transform its development model. With nearly 20 million doses of Covid-19 vaccine administered to date, the country was already a leader in Africa. It is taking a further step forward by soon manufacturing its own vaccines through a public-private partnership. It is therefore a substantial step that has just been taken, under the leadership of King Mohammed VI, in order to preserve the country’s health sovereignty. Three agreements were signed during the ceremony to launch the project to manufacture and syringe the anti-Covid19 vaccine and other vaccines, which was presided over on Monday 5 July by King Mohammed VI at the Royal Palace in Fez.

The first agreement was signed with the Chinese pharmaceutical giant Sinopharm, following the telephone conversation on August 31 between King Mohammed VI and Chinese President Xi Jinping. Another was also signed with the fifth largest drug manufacturing group in the world, Recipharm, to establish vaccine manufacturing capacity in Morocco.A contract for the provision of the filling facilities of the Moroccan pharmaceutical laboratory Sothema for the manufacture of the vaccine anti-Covid-19 (owned by the company Sinopharm) was signed by its CEO, Lamia Tazi, and by the Minister of Health, Khalid Ait Taleb. The three agreements are considered sufficient to build an anti covid-19 shield not only to protect Morocco, but also to manufacture and distribute vaccines in Africa.

To protect the health of its citizens, the Kingdom has implemented a full-scale strategy

500 million dollars is the amount that Morocco will mobilize in order to provide the Kingdom with industrial and biotechnological capacities dedicated to the manufacture of vaccines in Morocco.The Kingdom will proceed to this implementation according to a precise schedule, to secure the urgent needs in vaccines Covid-19 on the short term, for the production of vaccines of the national plan of immunization in the medium term and in order to build a continental platform of research and development in the long term.

The goal is to create a continental vaccine and biotherapeutics champion within the next five years. To achieve this goal, three phases have been proposed to carry out this project. The first one consists in ensuring the filling capacity in clean room for the anti-covid19 vaccine responding to the immediate sanitary imperative. In this context, Sothema will be required to make its aseptic filling facilities available to the government for the manufacture of the Sinopharm vaccine in Morocco.

The second is the creation of a new production center for vaccines and biotherapies (active substances and finished products). This new center has been the subject of a Memorandum of Understanding between the Moroccan government and the company Recipharm. The Swedish giant will help in managing the construction of the vaccine filling plant. It will also contribute to the training of work teams in Morocco and in Europe in Recipharm’s factories, to the transfer of clean room manufacturing technologies and adequate know-how, to the management of the factory in Morocco and to the guarantee of the quality of the manufactured batches.

The work on this phase starts this year with the establishment of a governance and project management, the start of the infrastructure development, the creation of a business plan and the creation and execution of a master plan.

Finally, regarding the last phase of the project, Morocco aims to develop a production of biotherapies, mRNA active ingredients and biosimilars. This phase starts in 2024 with the objective of creating an African biopharmaceutical and vaccine innovation cluster in Morocco.

Thus, Morocco should become, in the next few years, a leading biotechnology platform on the African continent in the field of the vaccine industry after succeeding in building a regional industrial hub in automotive, aeronautics, or logistics.

Previous Post

The Big Picture in the World of Tiny Creatures.

Next Post

Sales Expert Aaron Civitarese Explains The Mindset to Online Success

Next Post
Sales Expert Aaron Civitarese Explains The Mindset to Online Success

Sales Expert Aaron Civitarese Explains The Mindset to Online Success

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

From Homelessness to Restaurant Owner: Chefrock’s Story of Resilience

From Homelessness to Restaurant Owner: Chefrock’s Story of Resilience

February 8, 2023

Kazakhstan Providing Emergency Aid to Turkey

February 8, 2023

5 Beautiful Floral Fragrances You Must Try!

February 8, 2023

Exclusive Interview with Global Business Leader, Entrepreneur and Principle of Sales Acceleration Group, Kriste Jones

February 8, 2023

The responsibility of leading the journey towards net-zero should be shouldered by corporations, not nations.

February 7, 2023

Steady Stack Titans Hits Top 30 Highest Market Cap in Global NFT Market. Why Top 5 is Possible for the Dark Horse of the Bear Market.

February 7, 2023

The Rise of Electric Luxury Cars: A Game Changer in the Automotive World

February 6, 2023

10 Ways to Boost Your Website

February 5, 2023

Five key benefits of PCI DSS compliance

February 4, 2023

Kazakhstan Strengthening Cooperation with Council of Europe

February 4, 2023

Watchlist 2023: Sweet Vinyl by Dreamour

February 3, 2023

Caleb Boxx, Founder of Automate Channels, on Working With and As a Freelance Video Automator

February 3, 2023
  • Home
  • About Us
  • Our Staff
  • Contact Us
  • Privacy Policy
  • Editorial Policy
  • Use of Cookies

© 2019 - The American Reporter

No Result
View All Result
  • Home
  • About Us
  • Our Staff
  • Contact Us
  • Privacy Policy
  • Editorial Policy
  • Use of Cookies

© 2019 - The American Reporter

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.